Whitney Notaro | Vice President-Investor Relations |
Doug Hirsch | Co-Founder and Co-Chief Executive Officer |
Trevor Bezdek | Co-Founder and Co-Chief Executive Officer |
Karsten Voermann | Chief Financial Officer |
Jailendra Singh | Truist |
Michael Cherny | Bank of America |
Eric Sheridan | Goldman Sachs |
Doug Anmuth | JPMorgan |
Stephanie Davis | SVB Securities |
Craig Hettenbach | Morgan Stanley |
Jonathan Yong | Credit Suisse |
Sandy Draper | Guggenheim Partners |
Steve Valiquette | Barclays |
Stan Berenshteyn | Wells Fargo |
Scott Schoenhaus | KeyBanc |
Robert Simmons | D.A. Davidson |
Ladies and gentlemen, and thank you for standing by. Welcome to the GoodRx Third Quarter 2022 Earnings Call.
As a reminder, today's conference call is being recorded. I will now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Please go ahead.